Nicotinic receptor abnormalities in Alzheimer's disease

Biological Psychiatry

Volumn 49, Issue 3, 2001, Pages 175-184

  Court, Jennifer ^a   Martin Ruiz, Carmen ^a   Piggott, Margaret ^a   Spurden, Dean ^a   Griffiths, Martin ^a   Perry, Elaine ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Cerebral cortex; Nicotinic acetylcholine receptors; Protein expression; Striatum; Thalamus

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN I 125; CYTISINE; EPIBATIDINE; LIGAND; MESSENGER RNA; MUSCARINIC RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ALZHEIMER DISEASE; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; IMMUNOCHEMISTRY; LATERAL RETICULAR NUCLEUS; LIGAND BINDING; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; THALAMUS;

EID: 0035251750     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01116-1     Document Type: Article

References (76)

1. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices
2. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases
3. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions
4. Biochemical assessment of neurotransmitter and metabolic dysfunction and cerebral atrophy in Alzheimer's disease
5. Comparison of regional expression of nicotinic acetylcholine receptor alpha 7 mRNA and [125I]-alpha-bungarotoxin binding in postmortem brain
6. 3H]nicotine binding in human postmortem brain
7. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer's patients
8. Nerve growth factor receptor-containing cholinergic neurons of the basal forebrain project to the thalamic reticular nucleus of the rat
9. Nicotinic receptors and cholinergic neurotransmission in the central nervous system
10. The fall and rise of neuronal alpha-bungarotoxin binding proteins
11. Nicotinic receptors in mammalian brain: Localization and relation to cholinergic innervation
12. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: Mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release
13. Autoradiographic evidence for nicotine receptors on nigralstriatal and mesolimbic dopaminergic neurons
14. Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication
15. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: α-Bungarotoxin and nicotine binding in the thalamus
16. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging
17. Distribution of nicotinic receptors in the CNS
18. The role of the nucleus basalis of Meynert and dementia: Review and reconsideration
19. Postmortem stability of α-bungarotoxin binding sites in mouse and human brain
20. Differential regulation of neuronal receptor binding sites following chronic nicotine administration
21. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment
22. Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic based therapies
23. Diffuse plaques in the striatum in Alzheimer's disease (AD): Relationship to the striatal mosaic and selected neuropeptide markers
24. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease
25. Nicotinic acetylcholine receptors during pre-natal development and brain pathology in human aging
26. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain
27. The hypoxic brain. Insights from ischemic research
28. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease
29. Nicotinic cholinergic receptors in Alzheimer's disease
30. Smoking and Alzheimer's disease: A review of the epidemiological evidence
31. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain
32. Neuronal nicotinic receptor subtypes
33. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
34. α4 But not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease
35. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
36. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
37. Discordance between tradtional pathology and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications
38. Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularis
39. Neuroreceptor changes in Alzheimer disease
40. Neuronal nicotinic receptors and their implications in ageing and neurodegenerative disorders in mammals
41. PET studies and cholinergic therapy in Alzheimer's disease
42. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography
43. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains - In vivo assessment using positron emission tomography
44. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam study
45. Clinical neurochemistry: Developments in dementia research based on brain bank material
46. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
47. 3H]nicotine binding in human cortex: Relative abundance in subicular complex
48. Cholinergic component of dementia and aging
49. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology
50. Nicotine (3H-nicotine) receptor binding in human brain: Characterization and involvement in cholinergic neuropathology
51. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease
52. Nicotine receptors are located on lateral geniculate nucleus terminals in cat visual cortex
53. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease
54. A postmortem study of brain nicotinic receptors in Parkinsonson's disease and Alzheimer's disease
55. Distribution of nicotinic receptors in the human hippocampus and thalamus
56. Correlations of nicotinic binding with neurochemical markers in Alzheimer's disease
57. Location of nicotinic and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: Evidence from thalamic and cortical lesions
58. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer's-type dementia
59. 125I]αbungarotoxin binding
60. Nucleus basalis lesions decrease α- and κ-bungarotoxins binding in rat cortex
61. Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease
62. Expression of the α3 nicotinic receptor subunit mRNA in human brain in aging and Alzheimer's disease
63. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]nicotine
64. Age-related changes in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human frontal cortex and hippocampus
65. Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history
66. Distribution of alpha 2, alpha 3, alpha 4 and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat
67. Beta-amyloid (1-42) binds to alpha nicotinic acetylcholine receptor with high affinity: Implications for Alzheimer's disease pathology
68. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains
69. Basal forebrain lesions differentially alter galanin levels and acetylcholinergic receptors in the hippocampus and neocortex
70. Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization
71. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease-histotopographical correlation with amyloid plaques and hyperphosphorylated tau-protein
72. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes
73. Presynaptic nicotinic ACh receptors
74. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease
75. Identification of four classes of brain nicotinic receptors using beta2 mutant mice
76. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors